{"id":"NCT01790659","sponsor":"U.S. Army Medical Research and Development Command","briefTitle":"Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama","officialTitle":"A Randomized, Double-blind, Pivotal Phase 3 Study of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Alone Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2016-01","completion":"2016-01","firstPosted":"2013-02-13","resultsPosted":"2017-08-23","lastUpdate":"2018-02-14"},"enrollment":399,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cutaneous Leishmaniasis"],"interventions":[{"type":"DRUG","name":"WR 279,396","otherNames":["Paromomycin/Gentamicin topical cream"]},{"type":"DRUG","name":"Paromomycin","otherNames":[]}],"arms":[{"label":"WR 279,396","type":"EXPERIMENTAL"},{"label":"Paromomycin","type":"EXPERIMENTAL"}],"summary":"This study is a pivotal Phase 3, randomized, double-blind, 3-site, two-group trial assessing the efficacy and safety of WR 279,396 Topical Cream and Paromomycin Alone Topical Cream in subjects with CL in Panama. The primary objective of this study is to determine if WR 279,396 results in statistically superior final clinical cure rates of an index lesion when compared with Paromomycin Alone for the treatment of CL in Panama expected to be caused by L panamensis.","primaryOutcome":{"measure":"Percent of Participants With Final Clinical Cure","timeFrame":"baseline (before the start of treatment), and on Study Days 20, 35 ± 2 days, 49 ± 4 days, 63 ± 7 days, 100 ± 14 days, and 168 ± 14 days","effectByArm":[{"arm":"WR 279,396","deltaMin":78.6,"sd":null},{"arm":"Paromomycin","deltaMin":77.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":1,"countries":["Panama"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":201},"commonTop":["Nasopharyngitis","Dermatitis contact","Pruritus","Application site injury","Headache"]}}